Paper · 37398564
The Wnt/β-catenin signaling pathway plays a role in drug-induced liver injury by regulating cytochrome P450 2E1 expression.
Shin YS and 7 others. Toxicol Res, 2023. Cited by 11 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The Wnt/β-catenin signaling pathway plays a role in drug-induced liver injury by regulating cytochrome P450 2E1 expression. Papers, record 37398564. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37398564
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Wnt/β-catenin signaling pathway plays a role in drug-induced liver injury by regulating cytochrome P450 2E1 expression.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12,570,712 | Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways. | Curr Med Chem | 2003 | https://conductscience.org/library/papers/12570712 | PubMed |
| 2 | 15,458,572 | Peroxynitrite decomposition catalyst ameliorates renal damage and protein nitration in cisplatin-induced nephrotoxicity in rats. | BMC Pharmacol | 2004 | https://conductscience.org/library/papers/15458572 | PubMed |
| 3 | 19,275,551 | Role of NF-kappaB in the regulation of cytochrome P450 enzymes. | Curr Drug Metab | 2009 | https://conductscience.org/library/papers/19275551 | PubMed |
| 4 | 22,511,898 | Revision and update on clinical practice guideline for liver cirrhosis. | Korean J Hepatol | 2012 | https://conductscience.org/library/papers/22511898 | PubMed |
| 5 | 16,496,347 | Zonal gene expression in murine liver: lessons from tumors. | Hepatology | 2006 | https://conductscience.org/library/papers/16496347 | PubMed |
| 6 | 22,185,839 | Cytochrome P-450 CYP2E1 knockout mice are protected against high-fat diet-induced obesity and insulin resistance. | Am J Physiol Endocrinol Metab | 2012 | https://conductscience.org/library/papers/22185839 | PubMed |
| 7 | 16,799,984 | Enhancement by pyrazole of lipopolysaccharide-induced liver injury in mice: role of cytochrome P450 2E1 and 2A5. | Hepatology | 2006 | https://conductscience.org/library/papers/16799984 | PubMed |
| 8 | 9,772,215 | Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null mice. | Toxicol Appl Pharmacol | 1998 | https://conductscience.org/library/papers/9772215 | PubMed |
| 9 | 22,670,697 | Wnt/beta-catenin signaling: a promising new target for fibrosis diseases. | Physiol Res | 2012 | https://conductscience.org/library/papers/22670697 | PubMed |
| 10 | 33,948,989 | Incidence, characteristics and risk factors for drug-induced liver injury in hospitalized patients: A matched case-control study. | Br J Clin Pharmacol | 2021 | https://conductscience.org/library/papers/33948989 | PubMed |
1 to 10 of 55
See all 55 referencesCited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,872,022 | Divergent Hypoxia-Inducible Factor 2‑Alpha Signaling in Alcoholic Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease. | ACS Pharmacol Transl Sci | 2026 | https://conductscience.org/library/papers/42872022 | PubMed |
| 42,259,768 | CYP2E1 and CYP2D6 in Anti-Tuberculosis Drug-Induced Liver Injury: Mechanisms, Epigenetic Regulation, and Translational Implications. | Clin Transl Sci | 2026 | https://conductscience.org/library/papers/42259768 | PubMed |
| 41,249,771 | Exploring the roles of cytochrome P450 enzymes and their inhibitors in cancers and non-neoplastic human diseases. | Arch Pharm Res | 2025 | https://conductscience.org/library/papers/41249771 | PubMed |
| 40,817,410 | The dual roles of peptidoglycans: NOD1 and NOD2 inversely regulate bone metabolism. | Exp Mol Med | 2025 | https://conductscience.org/library/papers/40817410 | PubMed |
| 40,157,625 | Inhibition of bromodomain and extra-terminal (BET) proteins with JQ1 exacerbates acetaminophen-induced hepatotoxicity by altering detoxification pathways and oxidative stress responses. | Chem Biol Interact | 2025 | https://conductscience.org/library/papers/40157625 | PubMed |
| 39,939,490 | Inhibitory effects of cornuside on human liver cytochrome P450 enzymes. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/39939490 | PubMed |
| 39,391,981 | Atractylodes Lancea and Its Constituent, Atractylodin, Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease via AMPK Activation. | Biomol Ther (Seoul) | 2024 | https://conductscience.org/library/papers/39391981 | PubMed |
| 38,430,357 | Preparation and characterization of Sorafenib nano-emulsion: impact on pharmacokinetics and toxicity; an in vitro and in vivo study. | Drug Deliv Transl Res | 2024 | https://conductscience.org/library/papers/38430357 | PubMed |
| 37,779,594 | Effects of toxicants on endoplasmic reticulum stress and hepatic cell fate determination. | Toxicol Res | 2023 | https://conductscience.org/library/papers/37779594 | PubMed |
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37398564
GET https://conductscience.org/api/papers/v1/37398564/references?page=2